Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placebo
Authors:
- Joseph A FranciosaJFJoseph A Franciosa
- Karl T WeberKWKarl T Weber
- T.Barry LevineTLT.Barry Levine
- Gary T KinasewitzGKGary T Kinasewitz
- Joseph S JanickiJJJoseph S Janicki
- James WestJWJames West
- Marc M.J HenisMHMarc M.J Henis
- Jay N CohnJCJay N Cohn
- 1 September 1982
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 104 (3) , 587-594
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Long-Term Vasodilator Therapy with Trimazosin in Chronic Cardiac FailureNew England Journal of Medicine, 1980
- Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators.Circulation, 1980
- Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failureThe American Journal of Cardiology, 1979
- Functional capacity of patients with chronic left ventricular failureThe American Journal of Medicine, 1979
- Hydralazine in the management of left ventricular failureThe American Journal of Cardiology, 1979
- Effect of prazosin vs placebo on chronic left ventricular heart failure.Circulation, 1979
- Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failureThe American Journal of Cardiology, 1977
- Hemodynamic Improvement after Oral Hydralazine in Left Ventricular FailureAnnals of Internal Medicine, 1977
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Left Ventricular Performance During Muscular Exercise in Patients with and without Cardiac DysfunctionCirculation, 1966